BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31146172)

  • 21. An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.
    Wu J; Sanai N; Bao X; LoRusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():25-32. PubMed ID: 27318641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative determination of gracillin by HPLC-MS/MS after oral administration and its application to a pharmacokinetic study.
    Zhang X; Xue X; Zhao J; Guo Z; Ito Y; Sun W
    Steroids; 2016 Sep; 113():78-86. PubMed ID: 27394958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid chromatography-tandem mass spectrometric assay for eltrombopag in 50μL of human plasma: a pharmacokinetic study.
    Maddela R; Gajula R; Pilli NR; Siddiraju S; Maddela S; Makula A
    J Pharm Biomed Anal; 2014 Sep; 98():68-73. PubMed ID: 24887483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid and sensitive UHPLC-MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats.
    Wen D; Guo J; Jiang F; Huang C; Zhao Z; Lu G; Chen J; Qin L; Li Z; Wang X; Deng Z; Huang M; Chi CAS; On TJC; Zhong G
    J Pharm Biomed Anal; 2017 Feb; 134():71-76. PubMed ID: 27886572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies.
    He Y; Zhou L; Gao S; Yin T; Tu Y; Rayford R; Wang X; Hu M
    J Pharm Biomed Anal; 2018 Jan; 148():65-72. PubMed ID: 28965046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometry.
    Qin W; Zhang Z; Tian Y; Xu F; Wang N; Chen Y
    Biomed Chromatogr; 2007 Apr; 21(4):415-21. PubMed ID: 17221934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
    Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
    Biomed Chromatogr; 2014 Oct; 28(10):1366-70. PubMed ID: 24619951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid chromatography-tandem mass spectrometric assay for the quantitative determination of the tyrosine kinase inhibitor quizartinib in mouse plasma using salting-out liquid-liquid extraction.
    Retmana IA; Wang J; Schinkel AH; Schellens JHM; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():300-305. PubMed ID: 28772226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A liquid chromatography-tandem mass spectrometric assay for the antihypertensive agent azelnidipine in human plasma with application to clinical pharmacokinetics studies.
    Gao Y; Li B; Zhu B; Liu D; Zhao H; Fang Z; Wang H; Lou H
    Biomed Chromatogr; 2015 Jul; 29(7):970-4. PubMed ID: 25472837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
    Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
    Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Moghaddam-Helmantel IM; de Jonge MJ; Meyer T; Lam MH; Verweij J; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2009 Dec; 50(5):977-82. PubMed ID: 19628352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma.
    Peer CJ; Brown JL; Martin TJ; Roth J; Spencer SD; Brassil P; McNeill KA; Kreisl TN; Fine HA; Figg WD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():107-12. PubMed ID: 24239935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of acetylpuerarin and puerarin in rat plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study following intravenous and oral administration.
    Sun D; Xue A; Wu J; Zhang B; Yu J; Li Q; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 995-996():24-30. PubMed ID: 26021848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive LC-MS/MS-ESI method for simultaneous determination of montelukast and fexofenadine in human plasma: application to a bioequivalence study.
    Muppavarapu R; Guttikar S; Rajappan M; Kamarajan K; Mullangi R
    Biomed Chromatogr; 2014 Aug; 28(8):1048-56. PubMed ID: 24424850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioanalysis of farnesyl pyrophosphate in human plasma by high-performance liquid chromatography coupled to triple quadrupole tandem mass spectrometry and hybrid quadrupole Orbitrap high-resolution mass spectrometry.
    Sugimoto H; Iguchi M; Jinno F
    Anal Bioanal Chem; 2017 May; 409(14):3551-3560. PubMed ID: 28343347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
    Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extraction.
    Chou B; Adler RS; Meng M; Percey S; Dean B; Hop CE; Shin YG
    J Pharm Biomed Anal; 2012 Nov; 70():354-61. PubMed ID: 22717139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of an HPLC-MS-MS assay for determination of morellic acid in rat plasma: application to pharmacokinetic studies.
    Li Y; Zhang Q; Jiang D
    J Chromatogr Sci; 2015; 53(10):1695-700. PubMed ID: 26071609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.